Several Coronavirus vaccines reach late-stage trials


Operation Warp Speed, one of President Trump’s most important responses to the Coronavirus, is a historic partnership between the federal government, scientific community, and private sector to develop a safe COVID-19 vaccine in record time. Its goal is to produce 300 million doses of vaccine and have initial doses ready by January.
 
The once-in-a-generation effort is already achieving incredible results.
 
Clinical trials are showing promising early data, and manufacturing is already ramping up in preparation. Several vaccine candidates, including ones from AstraZeneca, Moderna, and Pfizer, are either in or about to begin late-stage trials.
 
Monday, President Trump toured a Fujifilm Diosynth Biotechnologies plant in North Carolina, where he gave reporters an update about progress toward a vaccine.
 
“Not only is Operation Warp Speed accelerating the development of a vaccine—we’re also directing a colossal industrial mobilization to ensure its rapid delivery,” he said. “Nothing has happened like this since the end of World War II.”  
 
Rather than rely on government command-and-control schemes to fight the Coronavirus, the Trump Administration is marshalling America’s scientific genius across the public, private, and nonprofit sectors. The FDA has authorized more than 185 tests under emergency authorities, including at least 30 antibody tests.
 
As a result of all these efforts, a number of promising therapies for the Coronavirus, such as Remdesivir, have been identified and are already in use.

Advertisement